Jun 2026 (Q2 FY26) — Aug 10, 2026
Sonida Senior Living Q2 FY26 — Strong Operational Performance and Strategic Growth
Read the full callSonida Senior Living (SNDA) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Sonida Senior Living earnings: last reported Mon, 10 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 208 | +122.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | -24.5 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$35.87 +0.22% · +$0.08
Performance +35.9% 1Y
1Y: $26.39 on 14 Oct 2025 → $35.87. High $43.07 (28 Jul 2026), low $25.53 (30 Oct 2025).
- Previous close
- $35.79
- 52-week range
- $25.53 – $43.07
- One year
- +36.91%
Overview
- Symbol
- SNDA
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Sonida Senior Living earnings calls (SNDA)
Financials
What the filings say
Net profit, year on year: −1465% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 75 | 92 | 92 | 94 | 98 | 98 | 123 | 208 |
| Expenses | 80 | 98 | 95 | 96 | 114 | 119 | 152 | 213 |
| Operating profit | — | — | 20 | — | — | — | — | — |
| Operating margin | — | — | 21.9% | — | — | — | — | — |
| Interest | 10 | 10 | 9 | 9 | 10 | 10 | 13 | 23 |
| Profit before tax | -14 | -6 | -13 | -2 | -27 | -30 | -41 | -24 |
| Tax rate | −0.5% | −0.8% | −0.6% | −4.8% | −0.3% | −0.3% | −0.5% | −1.3% |
| Net profit | -14 | -6 | -13 | -2 | -27 | -30 | -41 | -24 |
| EPS ($ per share) | -0.98 | — | -0.77 | -0.16 | -1.56 | — | -2.39 | -0.52 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -150 | -173 | -468 | -343 | -397 | -418 | -420 | -491 |
| Total liabilities | 1,114 | 1,253 | 982 | 734 | 719 | 688 | 712 | 789 |
| Fixed assets | 1,059 | 969 | 656 | 621 | 605 | 578 | 576 | 561 |
| Total assets | 1,149 | 1,268 | 703 | 729 | 661 | 621 | 842 | 845 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 37 | 5 | -7 | -29 | -3 | 11 | -2 | 24 |
| Cash from investing | -22 | 48 | 9 | -10 | -37 | -17 | -209 | -71 |
| Cash from financing | -2 | -60 | -16 | 99 | -23 | -7 | 232 | 38 |
| Net cash flow | 13 | -7 | -14 | 60 | -62 | -13 | 21 | -9 |
| Capital expenditure | -22 | -20 | -16 | -10 | -25 | -18 | -25 | -33 |
| Free cash flow | 15 | -15 | -22 | -39 | -27 | -7 | -27 | -9 |
Insider filings
49 filings between Dec 9, 2025 and Sep 2, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$10.99M
9 sales by 2 insiders
Compensation
not trading decisions- 16
- Award — granted as compensation
- 4
- Option exercise — converted options into shares
- 13
- Tax withheld — shares kept back by the company to cover tax
Also filed: 5 dispositions to the issuer, 2 other filings.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Simanovsky Michael | — | $10.65M | Sep 1, 2026 |
| Harris Benjamin P | — | $343.1K | Aug 14, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Simanovsky Michael Director | Other | 100,373 | — |
| Sep 1, 2026 | Simanovsky Michael Director | Sale | 97,581 | $3.75M |
| Aug 28, 2026 | Simanovsky Michael Director | Sale | 4,615 | $181.1K |
| Aug 28, 2026 | Simanovsky Michael Director | Sale | 21,792 | $831.6K |
| Aug 27, 2026 | Simanovsky Michael Director | Sale | 15,000 | $585.0K |
| Aug 26, 2026 | Simanovsky Michael Director | Sale | 15,086 | $617.6K |
| Aug 25, 2026 | Simanovsky Michael Director | Sale | 115,000 | $4.68M |
| Aug 21, 2026 | Simanovsky Michael Director | Other | 1,182,595 | $0 |
| Aug 14, 2026 | Harris Benjamin P Director | Sale | 3,195 | $127.1K |
| Aug 14, 2026 | Harris Benjamin P Director | Sale | 3,074 | $122.3K |
| Aug 10, 2026 | Simanovsky Michael Director | Disposition to issuer | 1,504,134 | — |
| Aug 10, 2026 | Simanovsky Michael Director | Option exercise | 97,371 | $3.12M |
| Aug 10, 2026 | Simanovsky Michael Director | Option exercise | 1,504,134 | $48.13M |
| Aug 10, 2026 | Simanovsky Michael Director | Disposition to issuer | 97,371 | — |
| Jul 1, 2026 | Nikodemus Anton D. Chief Operating Officer | Award | 12,118 | $0 |
| Jun 11, 2026 | Donohue Lilly Director | Award | 4,132 | $0 |
| Jun 11, 2026 | KRUEGER JILL M Director | Award | 4,132 | $0 |
| Jun 11, 2026 | Mauldin Stephen H Director | Award | 4,132 | $0 |
| Jun 11, 2026 | Harris Benjamin P Director | Award | 7,124 | $0 |
| Jun 11, 2026 | Martin J Chandler Director | Award | 4,132 | $0 |
| Jun 11, 2026 | Levinson Sam Director | Award | 6,412 | $0 |
| Jun 2, 2026 | Levy Max SVP & Chief Investment Officer | Tax withheld | 1,785 | $58.5K |
| May 19, 2026 | Levy Max SVP & Chief Investment Officer | Tax withheld | 1,405 | $51.9K |
| May 19, 2026 | Cober Timothy SVP & Chief Accounting Officer | Tax withheld | 346 | $12.8K |
| May 19, 2026 | Bailey Tabitha SVP & Chief Legal Officer | Tax withheld | 432 | $16.0K |
| May 19, 2026 | Ribar Brandon President & CEO | Tax withheld | 3,067 | $113.3K |
| May 19, 2026 | Detz Kevin EVP & Chief Financial Officer | Tax withheld | 1,952 | $72.1K |
| May 13, 2026 | Harris Benjamin P Director | Sale | 2,500 | $93.7K |
| Apr 17, 2026 | Detz Kevin EVP & Chief Financial Officer | Award | 12,723 | $0 |
| Apr 17, 2026 | Ribar Brandon President & CEO | Award | 23,023 | $0 |
| Apr 17, 2026 | Levy Max SVP & Chief Investment Officer | Award | 8,482 | $0 |
| Apr 17, 2026 | Bailey Tabitha SVP & Chief Legal Officer | Award | 4,847 | $0 |
| Apr 17, 2026 | Cober Timothy SVP & Chief Accounting Officer | Award | 3,635 | $0 |
| Apr 5, 2026 | Ribar Brandon President & CEO | Tax withheld | 7,010 | $225.6K |
| Apr 5, 2026 | Detz Kevin EVP & Chief Financial Officer | Tax withheld | 4,461 | $143.6K |
| Apr 5, 2026 | Cober Timothy SVP & Chief Accounting Officer | Tax withheld | 593 | $19.1K |
| Mar 11, 2026 | Simanovsky Michael Director | Option exercise | 1,504,134 | $48.13M |
| Mar 11, 2026 | Simanovsky Michael Director | Award | 1,834,951 | $49.07M |
| Mar 11, 2026 | Simanovsky Michael Director | Award | 224,829 | $6.01M |
| Mar 11, 2026 | Simanovsky Michael Director | Award | 87,530 | $2.34M |
| Mar 11, 2026 | Simanovsky Michael Director | Award | 1,592,406 | $42.58M |
| Mar 11, 2026 | Simanovsky Michael Director | Option exercise | 97,371 | $3.12M |
| Mar 9, 2026 | Detz Kevin EVP & Chief Financial Officer | Tax withheld | 2,917 | $106.9K |
| Mar 9, 2026 | Ribar Brandon President & CEO | Disposition to issuer | 14,353 | $0 |
| Mar 9, 2026 | Ribar Brandon President & CEO | Tax withheld | 6,472 | $237.1K |
| Mar 9, 2026 | Detz Kevin EVP & Chief Financial Officer | Disposition to issuer | 9,134 | $0 |
| Mar 9, 2026 | Cober Timothy SVP & Chief Accounting Officer | Disposition to issuer | 1,957 | $0 |
| Mar 9, 2026 | Cober Timothy SVP & Chief Accounting Officer | Tax withheld | 547 | $20.0K |
| Dec 9, 2025 | Bailey Tabitha SVP & Chief Legal Officer | Tax withheld | 402 | $12.2K |
| Sep 5, 2025 | Ribar Brandon President & CEO | Tax withheld | 809 | $20.9K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for SONIDA SENIOR LIVING, INC.
Free account. Everything above stays public.
Write why you follow SONIDA SENIOR LIVING, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading